Literature DB >> 8689570

Carbohydrate-protein interactions in vascular biology.

R M Nelson1, A Venot, M P Bevilacqua, R J Linhardt, I Stamenkovic.   

Abstract

Carbohydrate-protein interactions participate in a wide variety of biological and pathological events. In recent years, particular attention has been paid to the carbohydrate-protein interactions that occur in vascular biology. Sialylated oligosaccharides are ligands of a structurally diverse group of proteins that include the selectins and members of the immunoglobulin superfamily. Various glycosaminoglycans can be recognized by an overlapping set of proteins that include two of the selectins and CD44. Emerging knowledge of carbohydrate-protein interactions in human pathophysiology are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8689570     DOI: 10.1146/annurev.cb.11.110195.003125

Source DB:  PubMed          Journal:  Annu Rev Cell Dev Biol        ISSN: 1081-0706            Impact factor:   13.827


  22 in total

1.  Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.

Authors:  Y J Kim; L Borsig; H L Han; N M Varki; A Varki
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 2.  Overgrowth syndromes and the regulation of signaling complexes by proteoglycans.

Authors:  S B Selleck
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

3.  A protein with protective properties against the cellular defense reactions in insects.

Authors:  S Asgari; U Theopold; C Wellby; O Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 4.  Selectin ligands: will the real ones please stand up?

Authors:  A Varki
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

Review 5.  Perspectives on the significance of altered glycosylation of glycoproteins in cancer.

Authors:  Y J Kim; A Varki
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

Review 6.  Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

Authors:  R D Rosenberg; N W Shworak; J Liu; J J Schwartz; L Zhang
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

7.  Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.

Authors:  A Koenig; K Norgard-Sumnicht; R Linhardt; A Varki
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

8.  The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety.

Authors:  A Aspberg; R Miura; S Bourdoulous; M Shimonaka; D Heinegârd; M Schachner; E Ruoslahti; Y Yamaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

9.  Glycosaminoglycans from earthworms (Eisenia andrei).

Authors:  A-Rang Im; Youmie Park; Joon-Soo Sim; Zhenqing Zhang; Zhenling Liu; Robert J Linhardt; Yeong Shik Kim
Journal:  Glycoconj J       Date:  2009-12-16       Impact factor: 2.916

10.  Constitutive repression of interleukin-1alpha in endothelial cells.

Authors:  Gregory J Brunn; Soheyla Saadi; Jeffrey L Platt
Journal:  Circ Res       Date:  2008-02-21       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.